It’s being called a game changer. The first new treatment for asthma attacks in 50 years is here. Researchers at King’s College in london just published results of a drug trial. It’s an injection that suppresses part of the immune system and work specifically on a type of asthma caused

Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used for the treatment of severe asthma.

Scientists have discovered that benralizumab, a drug currently used for severe asthma, can be repurposed in emergency settings to reduce hospitalisations and further treatment for asthma and COPD conditions.